AMERICAN PARKINSON DISEASE ASSOCIATION TO EDUCATE AND EMPOWER DURING PARKINSON’S DISEASE AWARENESS MONTH

APDA helps the Parkinson’s community live life to the fullest in April and year-round. With a diagnosis every six...see more minutes, public awareness and support are crucial. NEW YORK, NY, MARCH 11, 2025 – April is Parkinson’s Disease Awareness Month, and the American Parkinson Disease Association (APDA) will commemorate the month with a “Did You Know?” […]

Read More

FDA Approves New Adaptive DBS System

In exciting news, the FDA approved Medtronic’s deep brain stimulation (DBS) system known...see more as BrainSense™. Unlike standard DBS, which delivers electricity to the brain at pre-programmed settings, this technology can sense the brain’s electric signals, known as local field potentials or LFPs, and adjust the stimulation accordingly. This capability, […]

Read More

ONAPGO: A Newly-Approved Medication for OFF Periods in Parkinson’s

ONAPGOTM: A Newly-Approved Medication for OFF Periods in Parkinson’s Breaking News! The first subcutaneous (under the skin) apomorphine infusion,...see more now called ONAPGOTM, was approved by the Food and Drug Administration (FDA) on February 4, 2025. Apomorphine is a dopamine agonist whose effects have a rapid onset. It has been available in the US as a […]

Read More

CHAMPIONING HEALTH EQUITY: RESEARCHER’S QUEST TO EXPAND ADVANCE CARE PLANNING IN HISPANIC PD COMMUNITIES

As part of our 2024-2025...see more research funding, the American Parkinson Disease Association (APDA) was proud to award Danielle Shpiner, MD, an APDA Diversity in Parkinson’s Disease Research Grant, which is given to investigators exploring health inequities and/or differences among under-studied Parkinson’s […]

Read More

AMERICAN PARKINSON DISEASE ASSOCIATION FREE TWO-DAY VIRTUAL CONFERENCE RETURNS TO EDUCATE, EMPOWER, AND ENGAGE THE PD COMMUNITY

Two days of learning, activities, and inspiration featuring top expertsFebruary 19 & 20, 2025 NEW YORK, NY, JANUARY 6,...see more 2025 – The American Parkinson Disease Association (APDA) is pleased to announce that registration is open for its third annual APDA Virtual Parkinson’s Conference. Following the overwhelming success of its first two years – which combined […]

Read More

EPA Bans TCE, a Solvent Linked to PD

In an exciting development for the Parkinson’s disease (PD) community, the Environmental Protection Agency (EPA) banned two solvents, trichloroethylene...see more (TCE) and perchloroethylene, that are found in many common industry and household products such as cleaners, lubricants, and glue. Both have been found to contribute to the increased risk of various cancers and other health conditions. […]

Read More